Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00847431 · ClinicalTrials.gov registry record
Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD)
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 81
- Enrollment target
NCT00847431: Completed study, sponsored by Washington University School of Medicine.
NCT00847431 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00847431 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
The goal of this study is to determine the vulnerability of mood-related neurocircuitry in Parkinson Disease (PD) using deep brain stimulation of the subthalamic nucleus (STN DBS).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2008-12 |
| Est. Completion | 2015-12 |
What the finished NCT00847431 record still lists
NCT00847431 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00847431 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00847431 about?
NCT00847431 is a clinical study titled "Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD)". The goal of this study is to determine the vulnerability of mood-related neurocircuitry in Parkinson Disease (PD) using deep brain stimulation of the subthalamic nucleus (STN DBS).
What is the current status of trial NCT00847431?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2008-12. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT00847431?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia